Swedish Orphan Biovitrum AB (publ) updated earnings guidance for the year 2024. For the year, revenue is anticipated to grow by low double-digit percentage at CER (previously high single-digit).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
279.5 SEK | +0.98% |
|
-0.71% | +4.79% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.79% | 8.89B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-14.37% | 32.26B | |
+80.86% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
-56.23% | 8.83B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Updates Earnings Guidance for the Year 2024